J W Myung1, J H Kim1, J Cho1, I Park1, H Y Kim2, J H Beom3. 1. From the Department of Emergency Medicine (J.W.M., J.H.K., J.C., I.P., J.H.B.). 2. Biostatistics Collaboration Unit, Department of Biomedical Systems Informatics (H.Y.K.), Yonsei University College of Medicine, Seoul, Republic of Korea. 3. From the Department of Emergency Medicine (J.W.M., J.H.K., J.C., I.P., J.H.B.), wangtiger@yuhs.ac.
Abstract
BACKGROUND AND PURPOSE: The use of invasive cerebral angiography with CTA for active treatment of patients with suspected ischemic strokes has been increasing recently. This study aimed to identify the incidence of postcontrast acute kidney injury using baseline renal function when CTA and cerebral angiography were performed sequentially. MATERIALS AND METHODS: This retrospective observational study evaluated adults (18 years of age or older) with ischemic stroke who underwent CTA and cerebral angiography sequentially between 2010 and 2018. The incidence of postcontrast acute kidney injury was determined using the baseline estimated glomerular filtration rate. The value of the baseline estimated glomerular filtration rate at which the occurrence of postcontrast acute kidney injury increased was also determined. RESULTS: Postcontrast acute kidney injury occurred in 57/601 (9.5%) patients. Those with a baseline estimated glomerular filtration rate of <30 mL/min/1.73 m2 showed a higher incidence of acute kidney injury. Age, chronic kidney disease, medication (nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, β blockers, statins, and insulin) use following contrast media exposure, and serum albumin affected the incidence of postcontrast acute kidney injury. The incidence of postcontrast acute kidney injury increased when the baseline estimated glomerular filtration rate was <43 mL/min/1.73 m2. CONCLUSIONS: Patients with low baseline renal function had the highest incidence of postcontrast acute kidney injury after CTA and cerebral angiography, but no fatal adverse effects were documented. Thus, patients suspected of having a stroke should be actively managed with respect to neurovascular function.
BACKGROUND AND PURPOSE: The use of invasive cerebral angiography with CTA for active treatment of patients with suspected ischemic strokes has been increasing recently. This study aimed to identify the incidence of postcontrast acute kidney injury using baseline renal function when CTA and cerebral angiography were performed sequentially. MATERIALS AND METHODS: This retrospective observational study evaluated adults (18 years of age or older) with ischemic stroke who underwent CTA and cerebral angiography sequentially between 2010 and 2018. The incidence of postcontrast acute kidney injury was determined using the baseline estimated glomerular filtration rate. The value of the baseline estimated glomerular filtration rate at which the occurrence of postcontrast acute kidney injury increased was also determined. RESULTS: Postcontrast acute kidney injury occurred in 57/601 (9.5%) patients. Those with a baseline estimated glomerular filtration rate of <30 mL/min/1.73 m2 showed a higher incidence of acute kidney injury. Age, chronic kidney disease, medication (nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, β blockers, statins, and insulin) use following contrast media exposure, and serum albumin affected the incidence of postcontrast acute kidney injury. The incidence of postcontrast acute kidney injury increased when the baseline estimated glomerular filtration rate was <43 mL/min/1.73 m2. CONCLUSIONS:Patients with low baseline renal function had the highest incidence of postcontrast acute kidney injury after CTA and cerebral angiography, but no fatal adverse effects were documented. Thus, patients suspected of having a stroke should be actively managed with respect to neurovascular function.
Authors: M H Lev; J Farkas; V R Rodriguez; L H Schwamm; G J Hunter; C M Putman; G A Rordorf; F S Buonanno; R Budzik; W J Koroshetz; R G Gonzalez Journal: J Comput Assist Tomogr Date: 2001 Jul-Aug Impact factor: 1.826
Authors: Waleed Brinjikji; Andrew M Demchuk; Mohammad H Murad; Alejandro A Rabinstein; Robert J McDonald; Jennifer S McDonald; David F Kallmes Journal: Stroke Date: 2017-06-05 Impact factor: 7.914
Authors: Stacie L Demel; Aaron W Grossman; Jane C Khoury; Charles J Moomaw; Kathleen Alwell; Brett M Kissela; Daniel Woo; Matthew L Flaherty; Simona Ferioli; Jason Mackey; Felipe De Los Rios la Rosa; Sharyl Martini; Opeolu Adeoye; Dawn O Kleindorfer Journal: Stroke Date: 2017-03-03 Impact factor: 7.914
Authors: F O Lima; M H Lev; R A Levy; G S Silva; M Ebril; E C de Camargo; S Pomerantz; A B Singhal; D M Greer; H Ay; R Gilberto González; W J Koroshetz; W S Smith; K L Furie Journal: AJNR Am J Neuroradiol Date: 2009-12-31 Impact factor: 3.825
Authors: Steven D Weisbord; Martin Gallagher; Hani Jneid; Santiago Garcia; Alan Cass; Soe-Soe Thwin; Todd A Conner; Glenn M Chertow; Deepak L Bhatt; Kendrick Shunk; Chirag R Parikh; Edward O McFalls; Mary Brophy; Ryan Ferguson; Hongsheng Wu; Maria Androsenko; John Myles; James Kaufman; Paul M Palevsky Journal: N Engl J Med Date: 2017-11-12 Impact factor: 176.079
Authors: Aart J van der Molen; Peter Reimer; Ilona A Dekkers; Georg Bongartz; Marie-France Bellin; Michele Bertolotto; Olivier Clement; Gertraud Heinz-Peer; Fulvio Stacul; Judith A W Webb; Henrik S Thomsen Journal: Eur Radiol Date: 2018-02-09 Impact factor: 5.315
Authors: Benedikt Frank; Jordi Kühne Escolà; Leoni Biermann-Ratjen; Anika Hüsing; Yan Li; Philipp Dammann; Ulrich Sure; Christoph Kleinschnitz; Michael Forsting; Martin Köhrmann; Cornelius Deuschl Journal: J Clin Med Date: 2021-12-02 Impact factor: 4.241
Authors: Hyung Jin Lee; Hong Gee Roh; Sang Bong Lee; Yoo Sung Jeon; Jeong Jin Park; Taek-Jun Lee; Yu Jin Jung; Jin Woo Choi; Young Il Chun; Hee Jong Ki; Junsoo Cho; Ji Sung Lee; Hyun Jeong Kim Journal: Sci Rep Date: 2021-11-01 Impact factor: 4.379